MedTrace Logo

Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma

NCT00805896 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2008-12-31

No results posted yet for this study

Summary

Songyou Granule is a mixture of 6 herbs. Vitro and vivo studies showed that Songyou Granule can inhibit HCC cells grow, and HCC metastasis. Hypothesis of this study is that TACE plus Songyou Granule will improve outcome in patients with advanced hepatocellular carcinoma (HCC) compared with TACE.

Conditions

Interventions

DRUG

Songyou

4g/pack

DRUG

placebo

4g/pack

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Zhao-You Tang, MD · Fudan University

  • Boheng Zhang, MD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805896 on ClinicalTrials.gov